title: Which end point is more comprehensive in reflecting changes in irritable bowel syndrome treatment trials?
authors.forename: Ali
authors.initials: A
authors.lastname: Gholamrezaei
authors.forename: Kianoosh
authors.initials: K
authors.lastname: Nemati
authors.forename: Mohammad Hassan
authors.initials: MH
authors.lastname: Emami
mesh_terms: D000222:Adaptation, Physiological; D000223:Adaptation, Psychological; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000503:physiopathology / Q000523:psychology* / Q000628:therapy*; D008297:Male; D017060:Patient Satisfaction; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D018434:Sickness Impact Profile; D013997:Time Factors; D016896:Treatment Outcome